Estrella Immunopharma (ESLAW) Q4 2025 Earnings

12NovConfirmed
Q1 2025
Q2 2025
Q3 2025
Q4 2025
-0.19
-0.15
-0.11
-0.07

Details

Expected EPS
-0.1865
Actual EPS
-0.19
Surprise EPS
-0
Surprise Percent
+1.88%

Description

Estrella Immunopharma (ESLAW) has reported earnings of -0.19 per share for Q4 2025.

0 Comments

Share your thoughts